
Sign up to save your podcasts
Or


Dr Bauchner, Editor in Chief of JAMA, provides summary and commentary on the April 4, 2012 issue of JAMA, the Journal of the American Medical Association. Cetuximab and Stage III Colon Cancer Survival, Screening Ultrasound or MRI for Breast Cancer, Diagnostic Coding and Trends in Pneumonia Outcomes, Fluoroquinolones and Risk of Retinal Detachment, Management of Ovarian Cancer, Financial incentives in health care, Individualized breast cancer treatment.
By JAMA Network3.9
127127 ratings
Dr Bauchner, Editor in Chief of JAMA, provides summary and commentary on the April 4, 2012 issue of JAMA, the Journal of the American Medical Association. Cetuximab and Stage III Colon Cancer Survival, Screening Ultrasound or MRI for Breast Cancer, Diagnostic Coding and Trends in Pneumonia Outcomes, Fluoroquinolones and Risk of Retinal Detachment, Management of Ovarian Cancer, Financial incentives in health care, Individualized breast cancer treatment.

317 Listeners

542 Listeners

702 Listeners

506 Listeners

302 Listeners

260 Listeners

897 Listeners

3,365 Listeners

1,153 Listeners

90 Listeners

516 Listeners

375 Listeners

256 Listeners

440 Listeners

269 Listeners